Abstract:Background Inhibitor of differentiation 2 ( Id2 ) is a critical factor for cell proliferation and differentiation in normal vertebrate development. Most of the biological function of Id2 has been ascribed to its helix-loop-helix motif. Overexpression of Id2 is frequently observed in various human tumors, but its role for invasion potential in tumor cells is dispute. We aimed to reveal the role of Id2 in invasion potential in poorly invasive and estrogen receptor α (ERα)-positive MCF-7 and SKOV-3 cancer cells. Methods MCF-7 and SKOV-3 cells were stably transfected with the wild-type, degradation-resistant full-length or helix-loop-helix (HLH)-deleted Id2, respectively. Protein levels of Id2 and its mutants and E-cadherin were determined by western blot analysis and mRNA levels of Id2 and its mutants were determined by RT-PCR. The effects of Id2 and its mutants on cell proliferation were determined by [ 3 H]-thymidine incorporation assay and the 3- [4, 5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) dye method. The in vitro invasion potential of cells was evaluated by Transwell assay. Cell motility was assessed by scratch wound assay. The promoter activity of E-cadherin was determined by cotransfection and luciferase assays. Results Ectopic transfection of the wild-type Id2 markedly increased the protein and mRNA expression of Id2 in MCF-7 and SKOV-3 cells; the protein level but not mRNA level was further increased by transfection with the degradation-resistant Id2 form. The ectopic expression of Id2 or its mutants did not alter proliferation of either MCF-7 or SKOV-3 cells. Transfection of the wild-type Id2 significantly induced the invasion potential and migratory capacity of cells, which was further augmented by transfection with the degradation-resistant full-length or HLH-deleted Id2. E-cadherin protein expression and transactivation of the proximal E-cadherin promoter were markedly suppressed by the degradation-resistant full-length or HLH-deleted Id2 but not wild-type Id2. Ectopic expression of E-cadherin in MCF-7 and SKOV-3 cells only partially blunted the invasion potential induced by the degradation-resistant HLH-deleted Id2. Conclusion Overexpression of Id2 in ERα-positive epithelial tumor cells indeed increases the cells' invasive potential through a novel mechanism independent of dimerization to basic helix-loop-helix factors. E-cadherin contributes only in part to Id2-induced cell invasion when Id2 is accumulated to a higher level in some specific cell types.

Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors

Id 2 Predicts Poor Prognosis in Breast Cancer , Especially in Triple-Negative Breast Cancer , and Inhibits E-Cadherin Expression

Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition Via Up-Regulation of Notch3 in Breast Cancer

DSG2 and C-Myc Interact to Regulate the Expression of ADAM17 and Promote the Development of Cervical Cancer

Inhibitor of DNA Binding 2 Knockdown Inhibits the Growth and Liver Metastasis of Colorectal Cancer.

Data Supplement from ID1 Promotes Breast Cancer Metastasis by S100A9 Regulation

Downregulation of Id2 Increases Chemosensitivity of Glioma

Overexpression of ErbB2 in MCF-7 is Sufficient to Promote Cell Growth and Invasion

Id2-Dependent Anti-Tumor Immunity Promotes Anti-Cancer Therapies Effects

A Novel Role of Id-1 in Regulation of Epithelial-to-mesenchymal Transition in Bladder Cancer.

Significance Of Id-1 Up-Regulation And Its Association With Egfr In Bladder Cancer Cell Invasion

FHL2 Antagonizes Id1-Promoted Proliferation and Invasive Capacity of Human MCF-7 Breast Cancer Cells

FHL2 Inhibits the Id3-promoted Proliferation and Invasive Growth of Human MCF-7 Breast Cancer Cells.

MDM2 Promotes Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing Matrix Metalloproteinase-9

Inhibitor of Binding/differentiation 2 (id2) is Regulated by CCAAT/enhancer-binding Protein-Α (c/ebpα) and Promotes the Proliferation of Hepatocellular Carcinoma.

ID2 promotes tumor progression and metastasis in thyroid cancer

Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α

Id-1 Promotes Tumorigenicity And Metastasis Of Human Esophageal Cancer Cells Through Activation Of Pi3k/Akt Signaling Pathway

Interleukin-1 β-induced Id2 gene expression is mediated by Egr-1 in vascular smooth muscle cells

MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation.

ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway